Oregon Voters Said Yes To Using Psilocybin As A Mental Health Therapy. What’s Next?
Marijuana Stocks, Finance, & InvestingUncategorized January 8, 2021 MJ Shareholders
During the November election, Oregon voters approved a measure allowing licensed centers to provide psilocybin, the substance found in “magic mushrooms,” to help treat people experiencing a range of mental health issues. Oregon is the first state to approve such a program—and with that, eyes will now be on the state to see how it fares moving a substance that remains federally illegal into the sphere of reputable treatment.
According to a study published in November 2020 in the Journal of the American Medical Association, major depressive disorder affects more than 300 million people worldwide. In the U.S., about 10% of the adult population has been diagnosed with major depressive disorder in the past 12 months.
Gov. Kate Brown’s 2021-2023 budget includes $5.6 million to start implementingBallot Measure 109, which directs the Oregon Health Authority to create a state-licensed, psilocybin therapy program for the treatment of mental illnessesincluding depression, end-of-life psychological distress and post-traumatic stress disorder.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers